Why Altimmune (ALT) Is Up 29.7% After FDA Breakthrough Tag For Obesity-MASH Drug - And What's Next

Altimmune recently received FDA Breakthrough Therapy Designation for its obesity and MASH drug candidate pemvidutide, based on mid-stage data showing meaningful MASH resolution and plans for a 52-week ...
Fast Lane Only on MSN

2027 Porsche 911 GT3 RS facelift caught in clearest spy shots yet

The latest prototype of the 2027 Porsche 911 GT3 RS has stepped out into the snow with so little camouflage that it finally ...